Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años / Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period
Rev. méd. Chile
; 139(9): 1143-1149, set. 2011. ilus, tab
Article
em Es
| LILACS
| ID: lil-612237
Biblioteca responsável:
BR1.1
ABSTRACT
Background:
Macrolide and lincosamide resistance in Streptococcus pyogenes is due to the acquisition of mef, ermB and ermA genes, which confer different resistance phenotypes, namely M, MLSBconstitutive and MLSBinducible respectively. The last report of resistance in Chile was done in the period 1990-1998, in which resistance to macrolides was 5.4 percent, with M phenotype as the predominant one.Aim:
To characterize the evolution of erythromycin and clindamycin resistance and their associated genes in S. pyogenes strains isolated from patients with invasive and non-invasive infections in the period 1996 to 2005. Material andMethods:
Resistance to erythromycin and clindamycin was determined in 1,282 clinical isolates using the disk diffusion test. Resistant isolates were analyzed by polymerase chain reaction (PCR) for the presence of the above mentioned resistance genes.Results:
Global resistance to erythromycin and clindamycin was 3.5 and 0.7 percent respectively. Eighty percent of the resistant strains possessed the M. phenotype.Conclusions:
Resistance levels of S. pyogenes have decreased in Chile in the last years. Most resistant strains have M phenotype in contrast to many countries in which the MLSB constitutive phenotype is the predominant one.Palavras-chave
Texto completo:
1
Base de dados:
LILACS
Assunto principal:
Infecções Estreptocócicas
/
Streptococcus pyogenes
/
Clindamicina
/
Faringite
/
Eritromicina
/
Farmacorresistência Bacteriana
/
Antibacterianos
Limite:
Humans
País como assunto:
America do sul
/
Chile
Idioma:
Es
Ano de publicação:
2011
Tipo de documento:
Article